Mechanisms of arterial remodeling and neointima formation: an updated view on the chemokine system

Drug Discovery Today: Disease Mechanisms

Volumn 5, Issue 3-4, 2008, Pages

  Karshovska, Ela ^a   Schober, Andreas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; FRACTALKINE; KERATINOCYTE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOGENESIS; ARTERY INJURY; ARTERY OCCLUSION; ARTERY WALL; ATHEROSCLEROSIS; CELL PROLIFERATION; ENDOTHELIUM INJURY; IMMUNE RESPONSE; INTIMA; LYMPHOCYTIC INFILTRATION; MONOCYTE; NONHUMAN; PROTEIN FUNCTION; REVIEW; STEM CELL; T LYMPHOCYTE; WOUND HEALING;

EID: 67649404772     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.10.003     Document Type: Review

References (54)

1. Gerard C., and Rollins B.J. Chemokines and disease. Nat. Immunol. 2 (2001) 108-115
2. Weber C. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J. Mol. Med. 81 (2003) 4-19
3. Viola A., and Luster A.D. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 171-197
4. Gibbons G.H., and Dzau V.J. The emerging concept of vascular remodeling. N. Engl. J. Med. 330 (1994) 1431-1438
5. Mitchell R.N., and Libby P. Vascular remodeling in transplant vasculopathy. Circ. Res. 100 (2007) 967-978
6. Schober A., and Zernecke A. Chemokines in vascular remodeling. Thromb. Haemost. 97 (2007) 730-737
7. Schober A., and Weber C. Mechanisms of monocyte recruitment in vascular repair after injury. Antioxid. Redox. Signal. 7 (2005) 1249-1257
8. Saederup N., et al. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Circulation 117 (2008) 1642-1648
9. Perlman H., et al. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95 (1997) 981-987
10. Schober A., et al. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 108 (2003) 2491-2497
11. Zernecke A., et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 96 (2005) 784-791
12. Karshovska E., et al. A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury. J. Thromb. Haemost. 6 (2008) 1812-1815
13. Mazzinghi B., et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J. Exp. Med. 205 (2008) 479-490
14. Karshovska E., et al. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2540-2547
15. Nemenoff R.A., et al. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ. Res. 102 (2008) 1036-1045
16. Olive M., et al. p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in mice. J. Clin. Invest. 118 (2008) 2050-2061
17. Jung J.E., et al. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 19 (2005) 1296-1298
18. Fourcade O., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80 (1995) 919-927
19. Karshovska E., et al. The SDF-1α/CXCR4 axis mediates vascular progenitor cell mobilization and neointima formation by unsaturated lysophosphatidic acid. Clin. Res. Cardiol. 97 (2008) V1032 Suppl. 1
20. Sakihama H., et al. Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis. Circulation 110 (2004) 2924-2930
21. Zernecke A., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 102 (2008) 209-217
22. Roque M., et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 335-342
23. Zoll J., et al. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc. Res. 77 (2008) 471-480
24. Weber C., et al. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1997-2008
25. Weber C., et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood 97 (2001) 1144-1146
26. Baltus T., et al. Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 102 (2003) 1985-1988
27. von Hundelshausen P., et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103 (2001) 1772-1777
28. Schober A., et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106 (2002) 1523-1529
29. Zernecke A., et al. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) e10-e13
30. Krohn R., et al. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 116 (2007) 1812-1820
31. Zernecke A., et al. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood 107 (2006) 4240-4243
32. Yun J.J., et al. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation 109 (2004) 932-937
33. Horiguchi K., et al. Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy. J. Heart Lung Transplant. 21 (2002) 1090-1100
34. Taubman M.B., et al. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ. Res. 70 (1992) 314-325
35. Schober A., et al. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ. Res. 95 (2004) 1125-1133
36. Egashira K., et al. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ. Res. 90 (2002) 1167-1172
37. Tatewaki H., et al. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. J. Vasc. Surg. 45 (2007) 1236-1243
38. Schepers A., et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2063-2069
39. Saiura A., et al. Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1886-1890
40. Kimura H., et al. Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab. Invest. 78 (1998) 571-581
41. Ikeda Y., et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H2021-H2028
42. Ishibashi M., et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ. Res. 94 (2004) 1203-1210
43. Ancuta P., et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197 (2003) 1701-1707
44. Liu P., et al. CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2056-2062
45. Zeiffer U., et al. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ. Res. 94 (2004) 776-784
46. Boisvert W.A., et al. Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am. J. Pathol. 168 (2006) 1385-1395
47. Huo Y., et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 108 (2001) 1307-1314
48. Liehn E.A., et al. Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1891-1896
49. Walter D.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
50. Werner N., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1567-1572
51. Takamiya M., et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 751-757
52. Urao N., et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ. Res. 98 (2006) 1405-1413
53. Hristov M., et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res. 100 (2007) 590-597
54. Fujiyama S., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ. Res. 93 (2003) 980-989